| Infectivity tested at MOI = 30 | Receptor expression | ||
---|---|---|---|---|
Cells | Ad5/GFP | AdF35/GFP | CAR | CD46 |
(% positive cellsa) | (% mean fluorescence intensityb) | |||
Pancreatic carcinoma | ||||
 HEK293 | 98.98 ± 0.11 | 99.47 ± 0.11 | 100 | 100 |
 AsPC-1 | 8.47 ± 0.27 | 25.32 ± 0.57 | 71.6 | 182.4 |
 PANC-1 | 7.66 ± 0.50 | 28.35 ± 0.41 | 65.5 | 175.7 |
 BxPC-3 | 19.48 ± 0.62 | 68.95 ± 0.45 | 26.8 | 231.1 |
 MIA-PaCa-2 | 5.89 ± 0.54 | 65.41 ± 0.68 | 2.0 | 62.6 |
Esophageal carcinoma | ||||
 HEK293 | 87.20±0.52 | 78.05±0.70 | 100 | 100 |
 TE-1 | 8.06±1.17 | 53.47±0.10 | 11.5 | 321.5 |
 TE-2 | 0.79±0.14 | 10.15±0.44 | 33.7 | 160.2 |
 TE-10 | 16.15±0.52 | 35.33±0.67 | 25.9 | 99.7 |
 TE-11 | 22.86±0.53 | 42.82±0.74 | 39.1 | 290.2 |
 YES-2 | 5.09±1.29 | 51.54±0.36 | 0.3 | 131.7 |
 YES-4 | 27.18±0.16 | 61.23±0.07 | 47.2 | 135.2 |
 YES-5 | 22.18±0.32 | 69.97±0.89 | 27.0 | 176.3 |
 YES-6 | 16.59±0.25 | 27.63±0.17 | 53.1 | 120.4 |
 T.Tn | 0.49±1.00 | 21.60±0.15 | 14.3 | 208.9 |
Mesothelioma | ||||
 HEK293 | 93.7±0.1 | 93.8±0.4 | 100 | 100 |
 NCI-H2452 | 49.8±0.3 | 75.3±0.6 | 35.6 | 117.6 |
 NCI-H2052 | 7.4±0.3 | 81.5±0.5 | 0.7 | 174.7 |
 NCI-H226 | 78.5±1.2 | 81.9±1.5 | 84.0 | 164.7 |
 NCI-H28 | 85.5±0.4 | 95.1±0.2 | 17.8 | 150.4 |
 MSTO-211H | 8.7±0.3 | 67.9±0.9 | 2.3 | 56.0 |